PUT/NOVO-NORDISK B/550/2/21.06.24 Share Price

Warrant

DE000GP7XLZ5

Market Closed - BOERSE MUENCHEN 19:26:49 31/05/2024 BST
0.08 EUR -13.98% Intraday chart for PUT/NOVO-NORDISK B/550/2/21.06.24
1 month-65.37%
3 months-92.08%
Date Price Change
31/05/24 0.08 -13.98%
30/05/24 0.093 -6.06%
29/05/24 0.099 +1.02%
28/05/24 0.098 -22.83%
27/05/24 0.127 -0.78%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 07:26 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
Issuer Goldman Sachs
WKN GP7XLZ
ISINDE000GP7XLZ5
Date issued 12/07/2023
Strike 550 kr
Maturity 21/06/2024 (19 Days)
Parity 0.5 : 1
Emission price 17.43
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 17.22
Lowest since issue 0.017
Delta0x
Omega 0.000000
Premium0x
Gearing230x
Moneyness 0.5931
Difference Strike -377.3 kr
Difference Strike %-68.60%
Spread 2
Spread %96.15%
Intrinsic value 0.000000
Present value 1.079

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus